IATI BIOMED teva talks video clips May 13th

To view the full agenda click here
Elisabeth Kogan  
Sr. VP, Global Generic R&D and NTEs, Teva
Generic R&D
          Menashe Y. Levy, PhD
VP, Chief Technology Officer, Global R&D, Teva

 New Technologies on the Horizon

 

Rivka Kreitman, PhD
Sr. VP, Head of Global Search and Evaluation

Teva- not so Gerneric

          Dr. Michael Hayden  
Teva President of Global R&D and Chief Scientist Officer

Teva on the frontline in the fight against CNS disease

 

Round #1: Teva's NNE class of 2014  
Neuroscience Fast Move

Doctoral and Post-doctoral members of the Teva NNE ‘SPEED TALK’.

          Dr. Daniella Gutman
VP, Generic R&D IL and regional Generic R&D manager for the growth markets, Teva

There is nothing GENERIC about development of Generic Drugs

 

 
Dr. Iris Grossman
VP Personalized Medicine & Pharmacogenomics, Teva - Personalized Medicine in Teva

From bench to bedside
          Dr. Sharon Hausdorff
VP, Global Specialty and NTE IP, Teva
Building a Patent Portfolio- Lessons from Popular Fairy Tales

 

 
Prof. Tzipora Falik Zaccai
Director of the Institute of Human Genetics at the Western Galilee Hospital
Personalized medicine in the Galilee
          Dr. Arik Orbach, D.V.M
Head of Pharmacology, Discovery and Product Development, Teva
Conintuing our Collaboration: A Personal View  

 

 
Round #2: Teva's NNE class of 2013
Neuroscience Fast Move

Doctoral and Post-doctoral members of the Teva NNE ‘SPEED TALK’.